Coronavirus outbreak: Beneficiaries cannot choose between AstraZeneca-Oxford and Bharat Biotech vaccine initially
India’s Covid-19 vaccination campaign starting on January 16 with the AstraZeneca-Oxford vaccine and the homegrown Bharat Biotech jab will not offer beneficiaries the option to choose between the two, the Union health ministry has signalled. But online discussions and free-wheeling exchanges in medical circles across the country, doctors say, appear to reflect expectations among many that they would receive the AstraZeneca-Oxford vaccine called Covishield in India instead of the homegrown Covaxin. The health ministry said on Tuesday that 11 million doses of Covishield and 5.5 million doses ...